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Purpose: Little is known about how perceived social standing versus tradi-
tional socioeconomic characteristics influence medication adherence and blood
pressure (BP) among African American and white patients with hypertension
in the rural southeastern United States.
Methods: Perceived social standing, socioeconomic characteristics, self-
reported antihypertensive medication adherence, and BP were measured at
baseline in a cohort of rural African American and white patients (n = 495)
with uncontrolled hypertension attending primary care practices. Multivariate
models examined the relationship of perceived social standing and socioeco-
nomic indicators with medication adherence and systolic BP.
Findings: Medication nonadherence was reported by 40% of patients.
Younger age [β = 0.20; P = .001], African American race [β = -0.30;
P = .03], and lower perceived social standing [β = 0.08; P = .002] but not sex
or traditional socioeconomic characteristics including education and house-
hold income, were significantly associated with lower medication adherence.
Race-specific analyses revealed that this pattern was limited to African Amer-
icans and not observed in whites. In stepwise modeling, older age [β = 0.57,
P = .001], African American race [β = 4.4; P = .03], and lower medication ad-
herence [β = -1.7, P = .01] but not gender, education, or household income,
were significantly associated with higher systolic BP.
Conclusions: Lower perceived social standing and age, but not traditional
socioeconomic characteristics, were significantly associated with lower med-
ication adherence in African Americans. Lower medication adherence was
associated with higher systolic BP. These findings suggest the need for tailored,
culturally relevant medication adherence interventions in rural communities.
Key words health disparities, health services research, hypertension, medi-
cation adherence, social determinants of health.
the southeastern United States originally designated by
NHLBI in which local stroke mortality rates exceeded
national rates by at least 10%. Such communities may
have a variety of care delivery systems (private practice,
hospital-owned practice, federally funded community
health center) and a variety of pharmacies/programs
(chain, independent, 340b drug discount program) that
may impact medication use. Finally, many adherence in-
terventions have been broadly applied, often with limited
consideration of the factors that underlie inadequate ad-
herence, and often without tailoring or consideration of
targeting interventions to the unique needs of high-risk
subgroups such as rural-dwelling individuals.10 A more
careful understanding of patient perception of social
standing versus traditionally reported socioeconomic
variables, and the relationship to varying levels of med-
ication adherence in rural and underserved communities
in the stroke belt, may inform the development of specific
interventions that are more tailored for rural populations.
The larger cohort study from which this study was
derived examined factors associated with disparities in
blood pressure (BP) control patterns. Our hypothesis for
this study was that perceived social standing (reflecting
perceived role functioning and role potential and likely
influenced by life-course events) may directly influence
self-care behaviors such as medication adherence, which
in turn may influence BP. Individuals with lower per-
ceived social standing in the community may perceive
less need/less value regarding engagement in self-care be-
haviors, including medication taking, based on their per-
ceptions of themselves.
Therefore, the aims of this study were to examine the
relative importance of perceived social standing versus
traditional objective socioeconomic variables as correlates
of lower medication adherence in a rural community-
based setting in the southeastern United States, and to
characterize the relationship of lower medication ad-
herence with BP, an important clinical outcome. We
also sought to examine if these patterns regarding social
standing in the community were similarly observed in
both African Americans and whites in this southern rural
community. The relative importance of these associations
may help guide the development of rural and culturally
tailored interventions for patients with hypertension and
medication nonadherence.
Methods
This cross-sectional study used data collected at base-
line in a longitudinal cohort study, which took place in
2011-2014 in an impoverished rural county (ie, non-
Metropolitan Statistical Area) in North Carolina with a
Medication nonadherence and its relationship to uncon-
trolled hypertension is a complex problem that has been 
the subject of considerable investigation.1-5 Inadequate 
medication adherence is highly prevalent in hypertensive 
individuals and is associated with adverse cardiovascu-
lar (CV) outcomes, which may occur at an earlier age in 
minority patients.6,7 Published data identify a variety of 
patient and health system factors associated with med-
ication adherence and have led to important advances 
in the development of interventions designed to improve 
medication adherence.8-10 However, most of the available 
adherence data, which are often collected from insured 
populations in large metropolitan areas and/or from large 
health systems,1 may have limited applicability for unin-
sured or rural patients. Furthermore, there are limited 
data on medication adherence in rural patients, and these 
data are often from a single setting such as a university-
linked academic practice.11
Although most studies examine traditional demo-
graphic (eg, age, race, gender) and objective socioeco-
nomic (eg, income, education level) characteristics in 
health research, rural patients’ perception of their own 
social standing—how they perceive themselves in the 
social hierarchy of the community—may have a stronger 
influence on health behaviors than objective socioeco-
nomic indicators.12 In rating perceived social standing, 
individuals consider more than just their relative stand-
ing on objective socioeconomic measures (eg, income, 
education level); they also consider past circumstances 
and experiences (eg, educational quality), family history 
and resources (eg, wealth of extended family), future 
prospects and opportunities, as well as psychological fac-
tors (eg, self-esteem, respect from peers) that affect health 
trajectories. Therefore, perceived social standing is more 
than simply how many resources one has; rather, it is 
also how much one believes one has relative to others.12 
There may be a poor correlation between perceived social 
standing and objective socioeconomic measures, and this 
may vary by race. Perceived social standing may be in-
fluenced by a variety of current or past experiences, may 
be affected by distress or depression, and may influence 
self-care behaviors, including medication adherence, 
regardless of traditional demographic or socioeconomic 
characteristics. The relationship of perceived social stand-
ing to selected psychosocial and metabolic risk factors 
associated with CV disease among African Americans has 
been previously explored in the Jackson Heart Study, but 
that study did not include medication-taking behavior.13
Little is known about the relationship of perceived 
social standing versus traditional socioeconomic char-
acteristics and inadequate medication adherence in 
impoverished rural communities with large minority 
populations in the “stroke belt”—a geographic area in
large minority population. The design and rationale for 
the cohort study from which these data were obtained 
have been previously published.14 Briefly, the purpose of 
the larger cohort study was to examine the pragmatic ef-
fectiveness of implementing quality improvement strate-
gies designed to improve BP control and reduce racial 
disparities in BP control across 6 primary care practice 
settings. The practices included 3 private practices, a 
hospital-owned practice, and 2 community health cen-
ters. These practices varied in size from single provider 
practices to multispecialty group practices. Patients in the 
study cohort were recruited among active hypertensive 
patients attending 1 of the 6 primary care practices. Pa-
tients were identified and referred by each practice as 
follows. Three rural practices provided a list of adult pa-
tients with a history of at least 1 visit in the last year 
with an uncontrolled systolic BP measurement (systolic 
mmHg). Three rural practices were not able to generate 
a list from their electronic health record and a revised 
recruitment strategy was developed for them. In these 3 
practices, staff members documented the office BP mea-
surement for each adult patient with an established di-
agnosis of hypertension seen during routine patient care 
and faxed these lists to study personnel weekly. Study 
personnel then identified patients from these submitted 
lists with a diagnosis of hypertension and an uncontrolled 
systolic BP (systolic BP >150 mmHg). For all 6 practices, 
each identified patient received a mailed letter, signed by 
the primary care practice leader(s), inviting them to par-
ticipate in the study. Approximately 1 week later, each 
of these potential study patients received a phone call 
from the research staff to determine interest and eligibil-
ity. Each potential study patient was invited to schedule 
an appointment to learn more about the study. Each pa-
tient was offered a $40.00 gift card for completing the 
enrollment visit and baseline blood work. Recruitment 
of the final cohort varied widely across the 6 rural prac-
tices as follows: Practice 1: 29.0% of the cohort; Practice 
2: 40.6% of the cohort; Practice 3: 3.6% of the cohort; 
Practice 4: 11.2% of the cohort; Practice 5: 9.7% of the 
cohort; Practice 6: 5.9%. The overall refusal rate among 
patients approached for participation was approximately 
45%.
Baseline Visit and BP Measurement
For the baseline enrollment visit, each patient visited a 
separate study coordinating center in the county and pro-
vided informed consent approved by the University of 
North Carolina-Chapel Hill’s Institutional Review Board. 
Consenting patients had their BP measured at the coor-
dinating center, using standard techniques, in the seated 
position 3 times and averaged; they also provided detailed
Figure 1 Ten-Rung Perceived Social Standing in the Community
Measure.a
demographic and medication adherence responses on
questionnaires coordinated by trained research assistants.
Perceived Social Standing Measure
Perceived social standing in the community was assessed
using a validated self-anchoring scale with a pictorial
format (Figure 1) representing a 10-rung “social ladder,”
which allows the respondents to consider their past
and present social circumstances to more accurately
describe their perceived social status.15,16 This measure
was originally developed based on a premise that soci-
eties are structured in hierarchies like ladders, with the
rungs representing the resources and/or social capital
necessary to live a prosperous, healthy, and secure life.
The investigators included this measure because of the
limitations of traditional socioeconomic measures in
rural impoverished communities and because of prior
work with the instrument including examining the
role of race.12,13,15 The authors posited that perceived
social standing may have a profound impact on health
behaviors, including medication-taking behaviors, re-
gardless of the influence of more traditional measures
of socioeconomic status (ie, education, income). For
example, some individuals, despite limited income and
education, may perceive an elevated social standing in
the local community that may positively influence health
behaviors. Finally, we examined whether perceived
supply divided by [last refill date - first refill date + days’
supply of last refill date].
Potential Reasons for Medication
Nonadherence Measure
The patient was asked to bring in all medication contain-
ers, and all medications and dosages were recorded at the
enrollment visit and the antihypertensive medications
identified. Patients were asked a series of investigator-
developed questions that explored potential reasons for
inadequate medication adherence including possible side
effects, cost-related nonfilling or stretching out of medica-
tions, and perceived need to continue therapy. Questions
about experiences with side effects included a list of pos-
sible drug-induced symptoms and the patient was asked
to “mark all that apply.” Five questions asked about po-
tential cost-related adherence behaviors, asking how of-
ten in the last 3 months the patient did each of 5 possible
behaviors ranging from “not filling a prescription because
of cost” to “use of herbal medicines or vitamins rather
than my prescription medicine because of the cost.” Each
question had 4 response options ranging from “at least
once a week” to “never.”
Statistical Analysis
Traditional demographic [age, race (African American
and white) and gender] and socioeconomic [highest
grade/education achieved and annual household in-
come] characteristics and perceived social standing
(10-item scale) were initially examined using descriptive
statistics. Pearson correlation, t test, and chi-square
analysis, for continuous and categorical variables, re-
spectively, were used to examine bivariate relationships
between demographic and socioeconomic variables,
perceived social standing, and both MMAS and systolic
BP. Responses to the 5 investigator-derived cost-related
nonadherence questions were recoded for analysis into
2 responses: “at least once a month up to once a week,”
which was considered as practicing cost-related nonad-
herence behaviors; and “very rarely or never” responses,
which were considered as not practicing cost-related
nonadherence behaviors. Patients using one or more of
these cost-related strategies were identified.
Stepwise linear regression was used to examine the re-
lationship of traditional demographic and socioeconomic
characteristics (age, race, gender, highest education level,
annual household income) and perceived social standing
(10-item scale) with self-reported medication adherence
(MMAS score ranging from 0 to 8) as the outcome of
interest. The initial model included age, race, and gender.
social status and its impact on medication-taking be-
haviors may be fundamentally different in different 
racial groups. The investigators specifically asked patients 
to evaluate their perceived social standing relative to 
“others in their community” because our anecdotal expe-
rience suggested that some individuals in impoverished 
rural communities may perceive a high level of social 
standing despite having limited income and education. 
Patients were shown a picture of the ladder (Figure 1) 
and were asked to rate their own standing in comparison 
to others in their community (score = 1-10 with higher 
scores indicating higher perceived social standing).
Demographic and Socioeconomic Measures
Traditional demographic information collected included 
date of birth/age, self-identified race (primarily African 
American and white participants in this study), gender, 
highest education level completed, current health in-
surance status (presence of any health insurance), and 
household income in the last year, assessed in a 13-
category scale ranging from <$5,000/year to $100,000/
year.
Medication Adherence Measures
Medication adherence was assessed using the 8-item 
Morisky Medication Adherence Scale (MMAS), a well-
validated self-report measure of medication adherence 
(score range 0-8 with 8 being perfect medication ad-
herence and <6 being indicative of inadequate medica-
tion adherence; α = 0.83).17 The MMAS has been used 
for many years in medication adherence research with 
the current 8-item scale adapted from an earlier 4-item 
version to more specifically address potential challenges 
or barriers to optimal adherence. The instrument has 
also been previously used among African Americans and 
whites with hypertension in North Carolina to explore 
racial differences in BP control.18 In a small subsample, 
community pharmacy fill/refill data were available for 
antihypertensive medications as an additional measure of 
medication adherence. The investigators sought to better 
understand the extent to which self-reported medication 
adherence was consistent with adherence as estimated 
from pharmacy fill/refill data. This subsample included 32 
patients attending just one of the rural practice sites who:
(1) provided additional consent for review of pharmacy 
records, (2) obtained their personal medication fill/refill 
data for a 1-year period prior to the enrollment date from 
the local pharmacy, and (3) made these records available 
to the study center for review. Using these data, the indi-
vidual medication possession ratio (MPR) was calculated 
for each subsample patient as follows: number of days’
Table 1 Demographic, Socioeconomic, and Clinical Characteristics of
the Cohort at Time of Enrollment (n = 495)
Parameter Value
Mean age (yr.) 57.3 ± 12.8
Race (% African American) 60%
Gender (% female) 68%
High school education or less (%) 72%
Annual household income (% <$40,000/yr.) 68%
No health insurance (%) 26%
Mean systolic BP at enrollment center (mmHg) 139 ± 22
Mean number of antihypertensive medications 2 ± 1.4
The second model added highest education level and an-
nual household income, and the final model added per-
ceived community social standing score. Subsequently,
an interaction term for race times perceived social stand-
ing was introduced into the model. Finally, race-specific
regression models were examined in African Americans
and whites to clarify race-specific relationships.
To examine the relative clinical importance of medi-
cation adherence (MMAS score) and its relationship to
BP, a second series of linear regression models were con-
structed with baseline systolic BP as the outcome of inter-
est, MMAS score as the independent variable, and with
age, race, gender, education level, and annual household
income as covariates. The initial model included age, race,
and gender. The second model added highest education
level and annual household income, and the final model
added medication adherence (MMAS score). Data were




While the initial cohort contained 525 patients with a his-
tory of uncontrolled hypertension referred from primary
care practices, only 495 had complete data available for
Table 2 Comparison of Traditional Demographic and Socioeconomic Characteristics and Low Perceived Social Standing in the Community in Rural
Patients With a History of Uncontrolled Hypertension by Medication Adherence Status
Adherent (n = 298) Nonadherent (n = 197)
Parameter (MMAS  6) (MMAS < 6) P value
Mean age (yr.) 59.3 ± 11.4 54.9 ± 14.1 < .001
Race (% African American) 60% 69% .05
Gender (% male) 33% 32% .85
High school education or less 74% 73% .90
% Uninsured 22% 31% .03
Household income % <$40,000/yr. 69% 70% .98
% Perceived community standing in lowest tertile 25% 34% .09
Figure 2 Relationship Between Perceived Social Standing in the Community andMedication Nonadherence (MMAS< 6.0) by Race Among Rural Patients
With a History of Uncontrolled BP.
Table 3 Final Multivariate Model Examining Characteristics Associated
With Medication Adherence (MMAS score) in Rural Primary Care Patients
With a History of Uncontrolled BP
Final Model β
Parameter (95% CI) P value
Age (yr.) 0.20 (0.01-0.03) .001
Race -0.30 (-0.60–0.4) .03
Gender -0.06 (-0.3-0.2) .70
Highest education level 0.03 (-0.3-0.3) .85
Household income/yr. -0.05 (-0.2-0.1) .62
Standing in community 0.08 (0.03-0.14) .002
cioeconomic variables and perceived social standing with
medication adherence (MMAS score); results are given
in Table 3. Age (younger), race (African American), and
lower perceived social standing but not traditional socioe-
conomic factors (ie, highest education level completed
and household income) were significantly associated with
lower medication adherence. However, as evidenced in
Figure 2, the significant relationship between perceived
social standing and medication nonadherence was ob-
served in African Americans but not in whites. When an
interaction term for race times perceived social standing
was introduced into the model, neither race (β = -0.49;
P = .24) nor perceived social standing (β = 0.02; P = .85)
were significant independent correlates of medication
adherence. To further investigate the relationship be-
tween race and perceived social standing and medication
adherence, the investigators ran race-specific regression
models. Among African Americans only (n = 297), both
age (β = 0.025; P = .0001) and perceived social standing
(β = 0.09; P = .011) were independent correlates of
medication adherence. Among whites only (n = 198),
neither age (β = 0.011; P = .19) nor perceived social
standing (β = 0.07; P = 0.15) was significantly associated
with medication adherence.
Multivariate Analysis: Correlates of Systolic BP
As expected, systolic BP was significantly and positively
correlated with increasing age (Pearson correlation =
0.31, P < .001). In a series of stepwise linear regression
models, we examined the association of demographic and
socioeconomic factors (age, race, sex, highest education
level, and annual household income), and medication
adherence (MMAS score) with measured systolic BP as
the clinical outcome of interest. As shown in Table 4, age
(older), race (African American), and lower medication
adherence scores but not traditional socioeconomic
factors (ie, highest education level completed and annual
household income) were significantly associated with
higher levels of systolic BP.
this analysis. Demographic, socioeconomic, and clinical 
characteristics are given in Table 1. African Americans 
had a significantly higher mean perceived social standing 
than whites (6.8 vs 6.2; P < .005) despite significantly 
lower annual household income (75% vs 57% with an-
nual household income <$40,000).
Initial Relationships With Medication 
Nonadherence
There were no significant differences in mean MMAS 
scores or mean systolic BP across the 6 practices. 
Approximately 40% of patients had an MMAS score of 
<6, indicative of inadequate medication adherence. The 
pharmacy claims data were used to calculate MPR from a 
subsample of 32 patients and demonstrated moderate 
correlation with the MMAS score (Pearson correlation 
coefficient = 0.54, P = .001). There was a significant 
correlation between perceived social standing in the 
community and both medication adherence (MMAS 
score) (r = 0.13, P < .01) and annual household income 
(r = 0.18, P < .01). Table 2 shows bivariate comparisons 
of demographic and socioeconomic characteristics by 
medication adherence category based on the MMAS 
score (<6 vs  6). Those with medication nonadherence 
(MMAS < 6) were significantly younger, more likely 
to be African American, more likely to be uninsured, 
and more likely to have lower perceived social standing 
(Table 2). Annual household income and highest ed-
ucation level were not significantly different between 
adherence groups (Table 2).
Figure 2 shows that among African Americans who 
reported low perceived social standing, there was a 
significantly higher proportion of patients reporting med-
ication nonadherence, while no significant relationship 
was evident among whites. Those reporting nonadher-
ence (MMAS < 6; n = 197) had a higher mean systolic 
BP (140 ± 24 mmHg vs 137 ± 21 mmHg; P = .23) and 
a significantly lower mean number of antihypertensive 
medications (2.1 ± 1.3 vs 2.4 ± 1.2; P = .02). Among 
those reporting medication nonadherence (MMAS < 6; 
n = 197), only 38% endorsed a cost-related reason 
for nonadherence. By contrast, among those reporting 
nonadherence, 75% reported that, on one or more 
occasions, they had stopped or reduced the dosage of an 
antihypertensive medication because it made them feel 
worse, without calling the doctor’s office.
Multivariate Analysis: Correlates of Medication 
Adherence Score
In multivariate regression modeling, we examined the in-
dependent association of traditional demographic and so-
Table 4 Final Multivariate Model Examining Characteristics Associated 
With Systolic BP in Rural Primary Care Patients With a History of Uncon-
trolled BP
Final Model β
Parameter (95% CI) P value
Age (yr.) 0.57 (0.40-0.74) .001
Race 4.4 (0.47-8.4) .03
Gender -3.7 (-7.7-0.21) .06
Highest education level 1.8 (-2.5-6.2) .40
Household income/yr. 0.60 (-2.4-3.6) .70
Medication Adherence (MMAS) -1.7 (-3.1–0.41) .01
Discussion
Evaluating patients with uncontrolled hypertension in
rural community-based practices is a common scenario,
and medication nonadherence is often suspected. While
much data have been collected regarding medication
nonadherence in different settings, little is known about
the prevalence and correlates of medication nonad-
herence in the subset of individuals with uncontrolled
hypertension who present in rural primary care practices
in the southeastern United States, often described as
the “stroke belt.” This study uniquely addresses this
population and reveals a self-reported medication non-
adherence rate of approximately 40%, with a modestly
greater prevalence among younger individuals, African
Americans, and the uninsured. These findings are consis-
tent with other studies of medication nonadherence.1-3
In contrast to some prior reports, however, we found
that traditional socioeconomic characteristics, including
highest education level completed and annual household
income level, were not significantly associated with
medication adherence.5 Instead, this study demon-
strates a stronger relationship of medication adherence
with the patient’s own perceived social standing in
the community, specifically among African Americans.
This differential finding by race is consistent with prior
research on socioeconomic status in the CARDIA study19
in which annual income was associated with perceived
social standing in whites but not in African Americans.
Prior research by Cené and associates has demon-
strated that there are important differences by race in
perceived social standing that are unrelated to annual
household income.20 African Americans appear to gauge
social standing in their community in ways that are not
closely related to traditional socioeconomic characteris-
tics. Adler et al16 suggest that as patients evaluate their
own social standing in the community, they may con-
sider past circumstances and experiences, family history
and resources, future prospects and opportunities, as well
as psychological factors that affect current and future
health trajectories. Higher perceived social standing,
particularly among African Americans, may also suggest
specific access to support systems and social capital
that may have positive and beneficial effects on health
behaviors including medication adherence behaviors.
Thus, this global assessment of social standing appears
to be more strongly associated with a variety of health
outcomes, including medication adherence, than tra-
ditional socioeconomic characteristics in rural-dwelling
African Americans, and suggests that it should be more
consistently evaluated. Additional research is needed
regarding the prevalence and conceptualization of per-
ceived social standing in rural and minority communities
and how this might be leveraged to improve health
behaviors.
Patients reporting nonadherence had a significantly
lower mean number of antihypertensive medications
than adherent patients. It is unclear if this reflects under-
reporting by nonadherent patients, inadequate treatment
intensification by providers because of nonadherence
concerns, or other factors.
Of particular interest, patients reporting nonadherence
endorsed cost-related reasons as a cause only approxi-
mately 38% of the time. However, the majority of pa-
tients had, on at least 1 occasion, stopped or reduced the
dose of an antihypertensive medication because it made
them feel worse. This finding underscores the relative im-
portance of drug-related side effects as a potential cause
of nonadherence. These data suggest that rural primary
care practices and local pharmacies might benefit from
more careful and directed questioning regarding non-
cost-related reasons for nonadherence. While cost-related
nonadherence has received considerable attention, our
findings suggest that a broader range of patient-specific
barriers to adherence need to be explored in this setting
and used to develop a culturally tailored strategy for im-
proving adherence.
This study shows that medication nonadherence
remains as a significant problem in rural southern com-
munities and that it is significantly related to perceived
social standing among African Americans. Furthermore,
the study demonstrates that both higher systolic BP
values and racial disparities in BP control persist in
these communities and are associated with medication
nonadherence. New strategies to more directly investi-
gate patient-perceived social standing as a predictor of
medication nonadherence, particularly among African
Americans, are needed.
This study has a number of limitations. The study
was cross-sectional in nature so a causal relationship
between demographic and socioeconomic characteristics,
medication nonadherence, and systolic BP cannot be
established. The study included only African American
and white patients in the rural southeastern United 
States; extrapolation to other racial groups or other 
locations cannot be assumed. Approximately 40% of 
individuals chose not to participate so some selection bias 
may be present in the findings.
In conclusion, in rural southern communities, med-
ication nonadherence is prevalent and among African 
Americans in the community is more strongly associated 
with perceived social standing than with traditional 
socioeconomic characteristics. Medication nonadher-
ence contributes to elevated BP, and it is not always 
cost-related. Despite national attention on medication 
nonadherence, these problems persist and new office-
and community-based strategies need investigation. 
Specifically, our findings suggest the need for more 
tailored and culturally relevant medication adherence 
interventions to facilitate BP control.
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